Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract

Cannabidiol (CBD) is a major phytocannabinoid from . It is currently widely available and widely used in the USA, but despite its rapid progress to market, the pharmacology and toxicology of both CBD and cannabidiol-rich cannabis extracts (CRCE) remain largely unknown. The goals of this study were t...

Full description

Saved in:
Bibliographic Details
Published in:Drug and chemical toxicology (New York, N.Y. 1978) N.Y. 1978), 2024-08, p.1
Main Authors: Ewing, Laura E, Skinner, Charles M, McGill, Mitchell R, Kennon-McGill, Stefanie, Clement, Kirsten, Quick, Charles M, Yee, Eric U, Williams, D Keith, Walker, Larry A, ElSohly, Mahmoud A, Gurley, Bill J, Koturbash, Igor
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 1
container_title Drug and chemical toxicology (New York, N.Y. 1978)
container_volume
creator Ewing, Laura E
Skinner, Charles M
McGill, Mitchell R
Kennon-McGill, Stefanie
Clement, Kirsten
Quick, Charles M
Yee, Eric U
Williams, D Keith
Walker, Larry A
ElSohly, Mahmoud A
Gurley, Bill J
Koturbash, Igor
description Cannabidiol (CBD) is a major phytocannabinoid from . It is currently widely available and widely used in the USA, but despite its rapid progress to market, the pharmacology and toxicology of both CBD and cannabidiol-rich cannabis extracts (CRCE) remain largely unknown. The goals of this study were to investigate the potential of a novel human microphysiological system to emulate CRCE-induced hepatotoxicity and pharmacological properties demonstrated in animal models. For this purpose, C57BL6/J male mice were subjected to dosing with either 0, 61.5, 184.5, or 615 mg/kg of CRCE for 10 days. The liver-on-chip system, incorporating human primary hepatocytes, sinusoidal endothelial cells, as well as Kupffer and stellate cells was subjected to 0, 300, 1,200, or 4,400 ng/mL of CRCE (8 h exposure followed by 16 h washout) for 5 days. Administration of CRCE in mice resulted in nearly 4-fold elevations of plasma ALT at 615 mg/kg (  
doi_str_mv 10.1080/01480545.2024.2388292
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3094471893</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3094471893</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-f683bc2506841c36417040fb4ad92b1c83438f5a6df27f828245421edc90f1f23</originalsourceid><addsrcrecordid>eNpNkElOxDAQRS0EgmY4AshLNmk8pp0lQkwSEhtYR46HxCixg53Q3UfilhhoJDZVpf9f_ZIKgHOMlhgJdIUwE4gzviSIsCWhQpCK7IEF5oQXZXb3_81H4DilN4QwqTg9BEe0wpyXnC_A58M8SA_fZ6lh7z5MLIIvVOdGmLZpMgOUCUo4hdDnspZRwyY63TrfwqkzsJUjbMy0NsZD6d0g-4x7Dbvv1ASjafPKDxw2ToU-tNsff-xkHOROCDafUNJ72TjtQl9Ep7o_IUGzmaJU0yk4sDnenO36CXi9u325eSienu8fb66fihEzPBW2FLRRhKNSMKxoyfAKMWQbJnVFGqwEZVRYLkttycoKIgjjjGCjVYUstoSegMvf3DGG99mkqR5cUqbvpTdhTjVFFWMrLCqa0YsdOjeD0fUY8wfitv57L_0CVICAHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3094471893</pqid></control><display><type>article</type><title>Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Ewing, Laura E ; Skinner, Charles M ; McGill, Mitchell R ; Kennon-McGill, Stefanie ; Clement, Kirsten ; Quick, Charles M ; Yee, Eric U ; Williams, D Keith ; Walker, Larry A ; ElSohly, Mahmoud A ; Gurley, Bill J ; Koturbash, Igor</creator><creatorcontrib>Ewing, Laura E ; Skinner, Charles M ; McGill, Mitchell R ; Kennon-McGill, Stefanie ; Clement, Kirsten ; Quick, Charles M ; Yee, Eric U ; Williams, D Keith ; Walker, Larry A ; ElSohly, Mahmoud A ; Gurley, Bill J ; Koturbash, Igor</creatorcontrib><description>Cannabidiol (CBD) is a major phytocannabinoid from . It is currently widely available and widely used in the USA, but despite its rapid progress to market, the pharmacology and toxicology of both CBD and cannabidiol-rich cannabis extracts (CRCE) remain largely unknown. The goals of this study were to investigate the potential of a novel human microphysiological system to emulate CRCE-induced hepatotoxicity and pharmacological properties demonstrated in animal models. For this purpose, C57BL6/J male mice were subjected to dosing with either 0, 61.5, 184.5, or 615 mg/kg of CRCE for 10 days. The liver-on-chip system, incorporating human primary hepatocytes, sinusoidal endothelial cells, as well as Kupffer and stellate cells was subjected to 0, 300, 1,200, or 4,400 ng/mL of CRCE (8 h exposure followed by 16 h washout) for 5 days. Administration of CRCE in mice resulted in nearly 4-fold elevations of plasma ALT at 615 mg/kg (  &lt; 0.01) and a dose-dependent decrease in intrahepatic miR-122. Elevated levels of ALT, paralleled by decreased intrahepatic and increased effluent levels of miR-122, were also observed in the liver-on-chip, although these results were not statistically significant. Exposure to CRCE resulted in a robust and dose-dependent induction of key cytochrome P450 enzymes, namely , ( ), , and ( ) in both mouse livers and liver-on-chip. The results of this study demonstrate the congruence between the responses observed in mouse and human liver-on-chip experimental systems and provide evidence of the potential microphysiological systems hold for translating animal data into clinical practice.</description><identifier>ISSN: 1525-6014</identifier><identifier>EISSN: 1525-6014</identifier><identifier>DOI: 10.1080/01480545.2024.2388292</identifier><identifier>PMID: 39155655</identifier><language>eng</language><publisher>United States</publisher><ispartof>Drug and chemical toxicology (New York, N.Y. 1978), 2024-08, p.1</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39155655$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ewing, Laura E</creatorcontrib><creatorcontrib>Skinner, Charles M</creatorcontrib><creatorcontrib>McGill, Mitchell R</creatorcontrib><creatorcontrib>Kennon-McGill, Stefanie</creatorcontrib><creatorcontrib>Clement, Kirsten</creatorcontrib><creatorcontrib>Quick, Charles M</creatorcontrib><creatorcontrib>Yee, Eric U</creatorcontrib><creatorcontrib>Williams, D Keith</creatorcontrib><creatorcontrib>Walker, Larry A</creatorcontrib><creatorcontrib>ElSohly, Mahmoud A</creatorcontrib><creatorcontrib>Gurley, Bill J</creatorcontrib><creatorcontrib>Koturbash, Igor</creatorcontrib><title>Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract</title><title>Drug and chemical toxicology (New York, N.Y. 1978)</title><addtitle>Drug Chem Toxicol</addtitle><description>Cannabidiol (CBD) is a major phytocannabinoid from . It is currently widely available and widely used in the USA, but despite its rapid progress to market, the pharmacology and toxicology of both CBD and cannabidiol-rich cannabis extracts (CRCE) remain largely unknown. The goals of this study were to investigate the potential of a novel human microphysiological system to emulate CRCE-induced hepatotoxicity and pharmacological properties demonstrated in animal models. For this purpose, C57BL6/J male mice were subjected to dosing with either 0, 61.5, 184.5, or 615 mg/kg of CRCE for 10 days. The liver-on-chip system, incorporating human primary hepatocytes, sinusoidal endothelial cells, as well as Kupffer and stellate cells was subjected to 0, 300, 1,200, or 4,400 ng/mL of CRCE (8 h exposure followed by 16 h washout) for 5 days. Administration of CRCE in mice resulted in nearly 4-fold elevations of plasma ALT at 615 mg/kg (  &lt; 0.01) and a dose-dependent decrease in intrahepatic miR-122. Elevated levels of ALT, paralleled by decreased intrahepatic and increased effluent levels of miR-122, were also observed in the liver-on-chip, although these results were not statistically significant. Exposure to CRCE resulted in a robust and dose-dependent induction of key cytochrome P450 enzymes, namely , ( ), , and ( ) in both mouse livers and liver-on-chip. The results of this study demonstrate the congruence between the responses observed in mouse and human liver-on-chip experimental systems and provide evidence of the potential microphysiological systems hold for translating animal data into clinical practice.</description><issn>1525-6014</issn><issn>1525-6014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkElOxDAQRS0EgmY4AshLNmk8pp0lQkwSEhtYR46HxCixg53Q3UfilhhoJDZVpf9f_ZIKgHOMlhgJdIUwE4gzviSIsCWhQpCK7IEF5oQXZXb3_81H4DilN4QwqTg9BEe0wpyXnC_A58M8SA_fZ6lh7z5MLIIvVOdGmLZpMgOUCUo4hdDnspZRwyY63TrfwqkzsJUjbMy0NsZD6d0g-4x7Dbvv1ASjafPKDxw2ToU-tNsff-xkHOROCDafUNJ72TjtQl9Ep7o_IUGzmaJU0yk4sDnenO36CXi9u325eSienu8fb66fihEzPBW2FLRRhKNSMKxoyfAKMWQbJnVFGqwEZVRYLkttycoKIgjjjGCjVYUstoSegMvf3DGG99mkqR5cUqbvpTdhTjVFFWMrLCqa0YsdOjeD0fUY8wfitv57L_0CVICAHw</recordid><startdate>20240819</startdate><enddate>20240819</enddate><creator>Ewing, Laura E</creator><creator>Skinner, Charles M</creator><creator>McGill, Mitchell R</creator><creator>Kennon-McGill, Stefanie</creator><creator>Clement, Kirsten</creator><creator>Quick, Charles M</creator><creator>Yee, Eric U</creator><creator>Williams, D Keith</creator><creator>Walker, Larry A</creator><creator>ElSohly, Mahmoud A</creator><creator>Gurley, Bill J</creator><creator>Koturbash, Igor</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20240819</creationdate><title>Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract</title><author>Ewing, Laura E ; Skinner, Charles M ; McGill, Mitchell R ; Kennon-McGill, Stefanie ; Clement, Kirsten ; Quick, Charles M ; Yee, Eric U ; Williams, D Keith ; Walker, Larry A ; ElSohly, Mahmoud A ; Gurley, Bill J ; Koturbash, Igor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-f683bc2506841c36417040fb4ad92b1c83438f5a6df27f828245421edc90f1f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ewing, Laura E</creatorcontrib><creatorcontrib>Skinner, Charles M</creatorcontrib><creatorcontrib>McGill, Mitchell R</creatorcontrib><creatorcontrib>Kennon-McGill, Stefanie</creatorcontrib><creatorcontrib>Clement, Kirsten</creatorcontrib><creatorcontrib>Quick, Charles M</creatorcontrib><creatorcontrib>Yee, Eric U</creatorcontrib><creatorcontrib>Williams, D Keith</creatorcontrib><creatorcontrib>Walker, Larry A</creatorcontrib><creatorcontrib>ElSohly, Mahmoud A</creatorcontrib><creatorcontrib>Gurley, Bill J</creatorcontrib><creatorcontrib>Koturbash, Igor</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Drug and chemical toxicology (New York, N.Y. 1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ewing, Laura E</au><au>Skinner, Charles M</au><au>McGill, Mitchell R</au><au>Kennon-McGill, Stefanie</au><au>Clement, Kirsten</au><au>Quick, Charles M</au><au>Yee, Eric U</au><au>Williams, D Keith</au><au>Walker, Larry A</au><au>ElSohly, Mahmoud A</au><au>Gurley, Bill J</au><au>Koturbash, Igor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract</atitle><jtitle>Drug and chemical toxicology (New York, N.Y. 1978)</jtitle><addtitle>Drug Chem Toxicol</addtitle><date>2024-08-19</date><risdate>2024</risdate><spage>1</spage><pages>1-</pages><issn>1525-6014</issn><eissn>1525-6014</eissn><abstract>Cannabidiol (CBD) is a major phytocannabinoid from . It is currently widely available and widely used in the USA, but despite its rapid progress to market, the pharmacology and toxicology of both CBD and cannabidiol-rich cannabis extracts (CRCE) remain largely unknown. The goals of this study were to investigate the potential of a novel human microphysiological system to emulate CRCE-induced hepatotoxicity and pharmacological properties demonstrated in animal models. For this purpose, C57BL6/J male mice were subjected to dosing with either 0, 61.5, 184.5, or 615 mg/kg of CRCE for 10 days. The liver-on-chip system, incorporating human primary hepatocytes, sinusoidal endothelial cells, as well as Kupffer and stellate cells was subjected to 0, 300, 1,200, or 4,400 ng/mL of CRCE (8 h exposure followed by 16 h washout) for 5 days. Administration of CRCE in mice resulted in nearly 4-fold elevations of plasma ALT at 615 mg/kg (  &lt; 0.01) and a dose-dependent decrease in intrahepatic miR-122. Elevated levels of ALT, paralleled by decreased intrahepatic and increased effluent levels of miR-122, were also observed in the liver-on-chip, although these results were not statistically significant. Exposure to CRCE resulted in a robust and dose-dependent induction of key cytochrome P450 enzymes, namely , ( ), , and ( ) in both mouse livers and liver-on-chip. The results of this study demonstrate the congruence between the responses observed in mouse and human liver-on-chip experimental systems and provide evidence of the potential microphysiological systems hold for translating animal data into clinical practice.</abstract><cop>United States</cop><pmid>39155655</pmid><doi>10.1080/01480545.2024.2388292</doi></addata></record>
fulltext fulltext
identifier ISSN: 1525-6014
ispartof Drug and chemical toxicology (New York, N.Y. 1978), 2024-08, p.1
issn 1525-6014
1525-6014
language eng
recordid cdi_proquest_miscellaneous_3094471893
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
title Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A02%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20quad%20liver-on-chip%20system%20as%20a%20tool%20toward%20bridging%20the%20gap%20between%20animals%20and%20humans%20regarding%20toxicology%20and%20pharmacology%20of%20a%20cannabidiol-rich%20cannabis%20extract&rft.jtitle=Drug%20and%20chemical%20toxicology%20(New%20York,%20N.Y.%201978)&rft.au=Ewing,%20Laura%20E&rft.date=2024-08-19&rft.spage=1&rft.pages=1-&rft.issn=1525-6014&rft.eissn=1525-6014&rft_id=info:doi/10.1080/01480545.2024.2388292&rft_dat=%3Cproquest_pubme%3E3094471893%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p141t-f683bc2506841c36417040fb4ad92b1c83438f5a6df27f828245421edc90f1f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3094471893&rft_id=info:pmid/39155655&rfr_iscdi=true